Skip to main content
. 2012 Mar 20;184(5):E260–E268. doi: 10.1503/cmaj.110773

Table 1:

Characteristics of 939 patients presenting with chest pain and no ST-segment elevation who underwent early measurement of cardiac troponin levels with a conventional troponin I assay and a high-sensitivity troponin T assay

Characteristic Assay result; no. (%) of patients*
All patients
n = 939
Troponin I positive
n = 246
Troponin I negative/high-sensitivity troponin T positive
n = 111
Troponin I negative/high-sensitivity troponin T negative
n = 582
Age, yr, median (IQR) 65 (56–76) 71 (60–79) 77 (69–83) 61 (53–72)
Sex, male 561 (59.7) 168 (68.3) 72 (64.9) 321 (55.2)
Ethnic background
 NZ European 743 (79.1) 195 (79.3) 99 (89.2) 449 (77.1)
 Other European 92 (9.8) 24 (9.8) 8 (7.2) 60 (10.3)
 Maori/Pacific Islander 36 (3.8) 12 (4.9) 2 (1.8) 22 (3.8)
 Other 68 (7.2) 15 (6.1) 2 (1.8) 51 (8.8)
History of ischemic heart disease 486 (51.8) 125 (50.8) 86 (77.5) 275 (47.3)
Prior revascularization 284 (30.2) 75 (30.5) 46 (41.4) 163 (28.0)
Current smoker 569 (60.6) 146 (59.3) 74 (66.7) 349 (60.0)
Hypertension 571 (60.8) 162 (65.9) 79 (71.2) 330 (56.7)
Diabetes mellitus 155 (16.5) 54 (22.0) 24 (21.6) 77 (13.2)
Dyslipidemia 541 (57.6) 141 (57.3) 68 (61.3) 332 (57.0)
Peripheral vascular disease 48 (5.1) 12 (4.9) 15 (13.5) 21 (3.6)
Family history of ischemic heart disease 564 (60.1) 145 (58.9) 59 (53.2) 360 (61.9)
Body mass index, median (IQR) 28 (25–31) 27 (24–31) 27 (24–30) 28 (25–31)
Creatinine level, mmol/L, median (IQR) 97 (88–115) 97 (80–115) 97 (80–124) 80 (71–97)
Time to presentation, h, median (IQR) 6.3 (3.3–13.3) 6.1 (3.3–14.9) 5.9 (3.5–10.0) 6.4 (3.3–13.4)
Ischemic changes on ECG 234 (24.9) 127 (51.6) 21 (18.9) 86 (14.8)
In-patient revascularization 163 (17.4) 113 (45.9) 3 (2.7) 47 (8.1)

Note: ECG = electrocardiogram, IQR = interquartile range, NZ = New Zealand.

*

Unless stated otherwise.

Patients self-identified as New Zealanders of European descent.